Bio-Tech Corporation has 7.7 million shares of common stock outstanding and 250,000, 5.8% semiannual bond outstanding par value $1500 each. The common stock currently sells for $45 share and has a beta of 1.05; the bonds have 20 years to maturity and sell for 96% of par. The market risk premium is 6.2% percent, T-bill are yielding 2.7%, and the company's tax rate is 18%. a. What is the firm's market value capital structure? b. If the company is evaluating a new investment project that has the same risk as the firm's typical project, what rate should the firm use to discount the project's cash flows? Shows all the step and formula. Don't round off until you get the answer.